Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLAPARIB vs OLARATUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLAPARIB vs OLARATUMAB: Safety Overview

Metric OLAPARIB OLARATUMAB
Total FAERS Reports 18,274 565
Deaths Reported 5,496 109
Death Rate 30.1% 19.3%
Hospitalizations 3,471 169
Average Patient Age 62.3 yrs 55.6 yrs
% Female Patients 79.9% 48.3%
FDA Approval Date Aug 17, 2017 N/A
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Discontinued Prescription